SCHEMBL18688086

SCHEMBL18688086

c1ccc2c(c1)[nH]c1c3ccccc3c3c4oc5ccccc5c4c4ccccc4c3c21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP3K11 Q16584 2/20 0.49
▸ MAP3K9 P80192 1/20 0.49
▸ GABRP O00591 2/20 0.47
▸ GABRD O14764 2/20 0.47
▸ GABRA1 P14867 2/20 0.47
▸ GABRB1 P18505 2/20 0.47
▸ GABRG2 P18507 2/20 0.47
▸ GABRB3 P28472 2/20 0.47
▸ GABRA5 P31644 2/20 0.47
▸ GABRA3 P34903 2/20 0.47
▸ GABRA2 P47869 2/20 0.47
▸ GABRB2 P47870 2/20 0.47
▸ GABRA4 P48169 2/20 0.47
▸ GABRE P78334 2/20 0.47
▸ GABRA6 Q16445 2/20 0.47
▸ GABRG1 Q8N1C3 2/20 0.47
▸ GABRG3 Q99928 2/20 0.47
▸ GABRQ Q9UN88 2/20 0.47
▸ CHEK1 O14757 2/20 0.42
▸ CDK5 Q00535 5/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18086412 0.94 MAP3K11 (0.51) MAP3K11MAP3K9GABRPGABRDGABRA1
SCHEMBL16049927 0.90 MAP3K11 (0.51) MAP3K11MAP3K9GABRPGABRDGABRA1
SCHEMBL19991873 0.89 MAP3K11 (0.56) MAP3K11MAP3K9GABRPGABRDGABRA1
SCHEMBL18688088 0.88 MAP3K11 (0.49) MAP3K11MAP3K9GABRPGABRDGABRA1
SCHEMBL30883881 0.85 MAP3K11 (0.59) MAP3K11MAP3K9GABRPGABRDGABRA1
SCHEMBL29506369 0.85 MAP3K11 (0.59) MAP3K11MAP3K9GABRPGABRDGABRA1
SCHEMBL17228831 0.85 MAP3K11 (0.59) MAP3K11MAP3K9GABRPGABRDGABRA1
SCHEMBL22011721 0.85 MAP3K11 (0.47) MAP3K11MAP3K9GABRPGABRDGABRA1
SCHEMBL14951799 0.83 KDM4E (0.45) MAP3K11MAP3K9MEN1KMT2AMAPT
SCHEMBL16275794 0.83 MAP3K11 (0.53) MAP3K11MAP3K9GABRPGABRDGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10840457-B2 Compound for organic electric element, organic electric element comprising the same and electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2020-11-17 — — US disclosed
WO-2017052099-A1 COMPOUND FOR ORGANIC ELECTRONIC DEVICE, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF 덕산네오룩스 주식회사 2017-03-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10840457-B2 Compound for organic electric element, organic electric element comprising the same and electronic device thereof PIEZO1, OR10J3, OCIAD1 MAP3K11 1831/4885MAP3K9 1328/4885GABRP 4674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback